Correlation Between Alphabet and Zentalis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Alphabet and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alphabet and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alphabet Inc Class C and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Alphabet and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alphabet with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alphabet and Zentalis Pharmaceuticals.
Diversification Opportunities for Alphabet and Zentalis Pharmaceuticals
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Alphabet and Zentalis is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Alphabet Inc Class C and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Alphabet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alphabet Inc Class C are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Alphabet i.e., Alphabet and Zentalis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Alphabet and Zentalis Pharmaceuticals
Given the investment horizon of 90 days Alphabet Inc Class C is expected to generate 0.28 times more return on investment than Zentalis Pharmaceuticals. However, Alphabet Inc Class C is 3.62 times less risky than Zentalis Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Zentalis Pharmaceuticals Llc is currently generating about -0.08 per unit of risk. If you would invest 17,030 in Alphabet Inc Class C on November 28, 2024 and sell it today you would earn a total of 511.00 from holding Alphabet Inc Class C or generate 3.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Alphabet Inc Class C vs. Zentalis Pharmaceuticals Llc
Performance |
Timeline |
Alphabet Class C |
Zentalis Pharmaceuticals |
Alphabet and Zentalis Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Alphabet and Zentalis Pharmaceuticals
The main advantage of trading using opposite Alphabet and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alphabet position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.The idea behind Alphabet Inc Class C and Zentalis Pharmaceuticals Llc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |